• Conceptual model of necessity of climacteric disorders of overcoming (Clinical lecture)

Conceptual model of necessity of climacteric disorders of overcoming (Clinical lecture)

HEALTH OF WOMAN. 2018.5(132):109–112; doi 10.15574/HW.2018.132.109

Dubossarskya Z.
SI «Dnepropetrovsk Medical Academy of the Ministry of Health of Ukraine», Dnipro

Problems and prospects of extension of life of woman are discussed in the given article, taking into account that МHТ gives an opportunity of improvement of quality of life with realized of minimum risks at the observance of international and Ukrainian recommendations. Creation of conceptual model of overcoming of climacteric disorders and cardiovascular events on the basis of totality of risk factors will allow to the hormonotherapy to improve indexes and life-span of woman.

Key words: quality of life, stopping HRT, menopause.

REFERENCES

1. Butenko GM. 2002. Vozrastnyie izmeneniya kak predposyilka k vozniknoveniyu patologii. Zdorove zhenschinyi 5:10–13.

2. Gasanova SH, Zaydieva YaZ, Gus AI. 2007. Effektivnost nizkodozirovannoy nepreryivnoy gormonoterapii u zhenschin v postmenopauzalnom vozraste. Akush. i gin. 4:59–61.

3. Gevorkyan MA. 2006. Opyit primeneniya gormonoterapii pri klimaktericheskih rasstroystvah. Farmateka 2(117).

4. Dubossarska YuO. 2006. Patofiziolohiia klimakteriiu i menopauzy u zhinok z porushenniamy systemy reproduktsii v anamnezi, stratehiia zamisnoi hormonalnoi terapii. Dys. d-ra med. nauk. K:372.

5. Isaeva AS, Volkov VI. 2017. Statinyi i zdorove zhenschiny: vliyanie na serdechno-sosudistuyu i reproduktivnuyu sistemy. Med. aspektyi zdorovya zhenschiny 7–8(112–113):53–57.

6. Kalashnikova MF, Kahturiya YuB, Melnichenko GA, Syich YuP. 2000. Ispolzovanie svoystv gestagennogo komponenta zamestitelnoy gormonalnoy terapii u bolnyih s endokrinopatiyami. Russkiy med. zhurnal 8;11:16–19.

7. Pines A, Sturdee DW, Machennan AH. 2014. Kachestvo zhizni i rol gormonalnoy terapii v period menopauzyi. Zdorove zhenschinyi 2(88):32–34.

8. K resheniyu problemy menopauzalnoy gormonalnoy terapii. Reproduktivna endokrinologiya. 2015. 4(24):92–93.

9. Lyubarova IB, Tihonovskaya OA, Alifirova VM. 2008. Osobennosti klinicheskogo techeniya klimaktericheskogo sindroma i sposob korrektsii vegetativnyih proyavleniy u zhenschin s hronicheskoy ishemiey golovnogo mozga. Ross. Vestnik akush.-ginek. 8;3:81–84.

10. Primenenie Femostona pri klimaktericheskih rasstroystvah i soputstvuyuschih zabolevaniyah. Med. aspektyi zdorovya zhenschinyi. 2008. 3(1):56–58.

11. Repina MA. 2012. Ne nado boyatsya novyih metodik, nado imi vladet. Per Speculum. 1:4–7.

12. Rukovodstvo po klimakteriyu. Pod. red. VP Smetnik, VI Kulakova. MIA. M. 2001:685.

13. Rukovodstvo po gormonalnoy terapii u zhenschin v period menopauzyi. Ispolnitelnyiy komitet Mezhdunarodnogo obschestva po menopauze. Climacteric. 2004. 7:8–11.

14. TobI de VIlErs, Tatarchuk TF, Dubossarska YuO ta In. 2016. NatsIonalniy konsensus schodo vedennya patsIEntok u klImakterIYi. Reproduktivna endokrinologIya 1(27):1–15.

15. Smetnik VP. 2013. Rezhimyi estrogenoterapii v klimakterii. Akush. i ginek. 2:25–30.

16. Teoriya i praktika endokrinnoy ginekologii. Pod red. prof. ZM Dubossarskoy, «Lira». 2010:398–418.

17. Shurpyak SA. 2017. Effektivnost i bezopasnost MGT v zavisimosti ot tipa, puti vvedeniya estrogenov i vida progesterona. Analiz dannyih klinicheskih issledovaniy i mezhdunarodnyih rekomendatsiy. Reproduktivna endokrinologіya 6(38):72–78.

18. Evolyutsiya zdorovya ot rozhdeniya do starosti. Med. aspektyi zdorovya zhenschinyi. 5(22):54–59. 2009.

19. Santen RJ, Allred DC, Ardoin SP et al. 2010. Postmenopausal hormone therapy: An Endocrine Society scientific statement. J Clin Endocrinol Metab. 9(1):S1-66. https://doi.org/10.1210/jc.2009-2509; PMid:20566620 PMCid:PMC6287288

20. Sturdee DW, Pines A on behalf of the IMS Writing Group. 2011. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 14:302–20. https://doi.org/10.3109/13697137.2011.570590; PMid:21563996

21. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause. 2010. 17:242–55. https://doi.org/10.1097/gme.0b013e3181d0f6b9; PMid:20154637